1. Home
  2. CWK vs CYTK Comparison

CWK vs CYTK Comparison

Compare CWK & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWK
  • CYTK
  • Stock Information
  • Founded
  • CWK 1784
  • CYTK 1997
  • Country
  • CWK United States
  • CYTK United States
  • Employees
  • CWK N/A
  • CYTK N/A
  • Industry
  • CWK Real Estate
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWK Finance
  • CYTK Health Care
  • Exchange
  • CWK Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • CWK 3.9B
  • CYTK 4.6B
  • IPO Year
  • CWK 2018
  • CYTK 2004
  • Fundamental
  • Price
  • CWK $14.86
  • CYTK $59.95
  • Analyst Decision
  • CWK Buy
  • CYTK Buy
  • Analyst Count
  • CWK 7
  • CYTK 16
  • Target Price
  • CWK $15.50
  • CYTK $76.73
  • AVG Volume (30 Days)
  • CWK 2.0M
  • CYTK 2.5M
  • Earning Date
  • CWK 10-30-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • CWK N/A
  • CYTK N/A
  • EPS Growth
  • CWK 1003.63
  • CYTK N/A
  • EPS
  • CWK 0.87
  • CYTK N/A
  • Revenue
  • CWK $9,742,200,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • CWK $7.24
  • CYTK $363.61
  • Revenue Next Year
  • CWK $5.73
  • CYTK $64.08
  • P/E Ratio
  • CWK $17.06
  • CYTK N/A
  • Revenue Growth
  • CWK 4.63
  • CYTK 2635.74
  • 52 Week Low
  • CWK $7.64
  • CYTK $29.31
  • 52 Week High
  • CWK $17.04
  • CYTK $61.48
  • Technical
  • Relative Strength Index (RSI)
  • CWK 36.80
  • CYTK 72.62
  • Support Level
  • CWK $15.58
  • CYTK $47.22
  • Resistance Level
  • CWK $15.96
  • CYTK $61.48
  • Average True Range (ATR)
  • CWK 0.40
  • CYTK 2.33
  • MACD
  • CWK -0.23
  • CYTK 0.55
  • Stochastic Oscillator
  • CWK 9.51
  • CYTK 87.83

About CWK Cushman & Wakefield plc

Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: